Literature DB >> 3361429

Biodegradable microspheres. VII: Alterations in mouse liver morphology after intravenous administration of polyacryl starch microparticles with different biodegradability.

T Laakso1, P Edman, U Brunk.   

Abstract

Semisynthetic polyacryl starch microparticles are being investigated as drug carriers. In the present paper the possible adverse effects, reflected as morphological alterations, of iv administration of polyacryl starch microparticles were studied in mice. The spleen, lungs, and kidneys displayed a normal morphology after microparticle administration, while dose-dependent reversible alterations of the liver morphology were observed. The alterations initially consisted of vacuolization of the hepatocytes along the sinusoids, followed by unicellular hepatocyte necrosis and formation of granulomas. Later, an increased number of mitotic cells reflected tissue generation and, after two weeks, the tissue morphology was essentially normalized, with the exception of an increased number of binucleated hepatocytes. After repeated administration of the particles in low doses, the same types of alterations were observed but the kinetics of tissue repair was slower. Possible mechanisms inducing these alterations are discussed and comparisons are made with the effects of synthetic polyacrylamide microparticles.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3361429     DOI: 10.1002/jps.2600770209

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole.

Authors:  E E Hassan; R C Parish; J M Gallo
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

Review 2.  Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease.

Authors:  Linda A Ban; Nicholas A Shackel; Susan V McLennan
Journal:  Int J Mol Sci       Date:  2016-03-14       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.